文献速递慢病管理预防保健、筛查与疫苗

在爱尔兰基层医疗中测量表观难治性高血压治疗依从性的可行性研究

Measuring adherence to therapy in apparent treatment-resistant hypertension: a feasibility study in Irish primary care.
PubMed 文献 · Br J Gen Pract · 2019-08-29

本研究在爱尔兰15家大学附属全科诊所邀请453例表观难治性高血压患者,采用质谱尿液分析检测用药依从性并结合动态血压监测评估白大衣高血压。52%(235例)患者参与,所有尿液样本均适合分析;24%部分依从、2%完全不依从,45%被归类为假性难治。研究表明在基层医疗中检测不依从性是可行的。

要点

  • 质谱尿液分析在基层医疗中检测降压药不依从性可行,所有样本均适合分析。
  • 表观难治性高血压患者中约四分之一部分或完全不依从治疗。
  • 动态血压监测显示45%患者为假性难治,提示需排除白大衣效应。

核心结论

  • 在表观难治性高血压患者中,使用质谱尿液分析检测用药不依从性在基层医疗中是可行的。
  • 约四分之一患者部分或完全不依从治疗,近半数被归类为假性难治。

研究设计与样本

  • 可行性研究,纳入爱尔兰15家大学研究附属全科诊所的453例表观难治性高血压患者。
  • 参与者接受质谱尿液分析检测依从性,并进行动态血压监测以评估白大衣高血压。

主要发现

  • 邀请的合格患者中52%(235例)参与。
  • 所有235份尿液样本(100%)均适合分析。
  • 174例(74%)完全依从,56例(24%)部分依从,5例(2%)完全不依从。
  • 206例患者同时接受动态血压监测,其中92例(45%)被归类为假性难治。
  • 依从状态与患者特征或药物类别之间未发现显著关联。

关键数值与推荐

  • 可行性操作化标准:至少50%患者参与且95%样本适合分析,本研究分别达到52%和100%。

临床怎么用

  • 对表观难治性高血压患者,可考虑使用质谱尿液分析客观评估用药依从性。
  • 应结合动态血压监测识别白大衣高血压导致的假性难治。

局限性

  • 本研究为可行性研究,样本来自大学研究附属全科诊所,结果外推需谨慎。
  • 将质谱尿液分析纳入个体患者咨询的方法及成本效果仍需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Apparent treatment-resistant hypertension (aTRH) is defined as uncontrolled blood pressure (BP) in patients taking three or more antihypertensive medications. Some patients will have true treatment-resistant hypertension, some undiagnosed secondary hypertension, while others have pseudo-resistance. Pseudo-resistance occurs when non-adherence to medication, white-coat hypertension (WCH), lifestyle, and inadequate drug dosing are responsible for the poorly controlled BP. AIM: To examine the feasibility of establishing non-adherence to medication, for the first time in primary care, using mass spectrometry urine analysis. Operationalisation would be established by at least 50% of patients participating and 95% of samples being suitable for analysis. Clinical importance would be confirmed by >10% of patients being non-adherent. DESIGN AND SETTING: Eligible patients with aTRH (n = 453) in 15 university research-affiliated Irish general practices were invited to participate. METHOD: Participants underwent mass spectrometry urine analysis to test adherence and ambulatory BP monitoring (ABPM) to examine WCH. RESULTS: Of the eligible patients invited, 52% (n = 235) participated. All 235 urine samples (100%) were suitable for analysis: 174 (74%) patients were fully adherent, 56 (24%) partially adherent, and five (2%) fully non-adherent to therapy. A total of 206 patients also had ABPM, and in total 92 (45%) were categorised as pseudo-resistant. No significant associations were found between adherence status and patient characteristics or drug class. CONCLUSION: In patients with aTRH, the authors have established that it is feasible to examine non-adherence to medications using mass spectrometry urine analysis. One in four patients were found to be partially or fully non-adherent. Further research on how to incorporate this approach into individual patient consultations and its associated cost-effectiveness is now appropriate.

来源:Br J Gen Pract,查看原文。版权归原作者所有。

引用

  1. Hayes P, Casey M, Glynn LG, et al. Measuring adherence to therapy in apparent treatment-resistant hypertension: a feasibility study in Irish primary care. Br J Gen Pract. 2019. PMID: 31358495. doi:10.3399/bjgp19X705077

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。